Planning

[키워드] age antibody Antibody Response Antibody responses Antibody titer Antibody titers Antigen antigens Antimicrobial responses best beta-coronavirus Care co-morbidities Cohort common cold conditions COVID-19 COVID-19 patient COVID-19 symptomatic patient Critical detectable Disease progression eight flu H1N1 hemagglutinin Heterologous Humoral immunity IgG immune response immune responses Immunity increased risk Infection Influenza lack majority morbidities neutralization Neutralizing antibodies neutralizing antibody neutralizing antibody titers neutralizing capacity not affected nucleoprotein outcome Patient care Planning recognizing recovered patient recovered patients S2 antigen SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 neutralization SARS-CoV-2 spike SARS-CoV-2 spike antigen SARS-CoV-2 spike protein seasonal coronavirus seasonal coronaviruses severe COVID-19 Spike protein survival Swab symptom onset symptomatic symptoms onset the antibody response the SARS-CoV-2 Therapeutic approach therapeutic approaches therapy understanding vaccination viral infection virus worsening
[DOI] 10.1038/s41467-021-22958-8 PMC 바로가기 [Article Type] Article